Inventor · disambiguated record
Leah Ranae Bresin Hanson
Also filed as: HANSON II LEAH RANAE BRESIN · HANSON LEAH R · HANSON LEAH RANAE BRESIN
12 granted patents·1 pending application·143 citations·filing 2005–2023
91Inventor score
Files withBAXALTA INC3HEALTHPARTNERS RES FOUNDATION3FREY II WILLIAM H2TAKEDA PHARMACEUTICALS CO2STANFORD RES INST INT1
Top patents by PatentIndex Score
13 records- 0196US9249424B2Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseasesUNIV MINNESOTA·Filed 2013·Granted Feb 2, 2016·79 cites·16 claims
- 0293US7618615B2Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemiaHEALTHPARTNERS RES FOUNDATION·Filed 2005·Granted Nov 17, 2009·27 cites·13 claims
- 0389US7776312B2Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2006·Granted Aug 17, 2010·9 cites·10 claims
- 0488US8609088B2Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseasesWOLF DANIEL A·Filed 2012·Granted Dec 17, 2013·13 cites·17 claims
- 0587US12503501B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin GTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Dec 23, 2025·0 cites·13 claims
- 0686US9205066B2Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 8, 2015·2 cites·11 claims
- 0782US9556260B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin GBAXALTA INC·Filed 2014·Granted Jan 31, 2017·4 cites·31 claims
- 0881US8568691B2Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoningFREY II WILLIAM H·Filed 2009·Granted Oct 29, 2013·2 cites·4 claims
- 0980US7989502B2Intranasal delivery of modafinilSTANFORD RES INST INT·Filed 2009·Granted Aug 2, 2011·6 cites·21 claims
- 1074US11851481B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin gTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Dec 26, 2023·0 cites·15 claims
- 1174US10144776B2Treatment of central nervous system disorders by intranasal administration of immunoglobulin GBAXALTA INC·Filed 2016·Granted Dec 4, 2018·1 cites·27 claims
- 1262US2019055307A1Treatment of central nervous system disorders by intranasal administration of immunoglobulin gBAXALTA INC·Filed 2018·Application pending·0 cites
- 1354US9808509B2Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous systemFREY II WILLIAM H·Filed 2008·Granted Nov 7, 2017·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Leah Ranae Bresin Hanson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →